{"paper_id":"c59ac5ce-0a0f-4159-a6fd-96b18baabb52","body_text":"~ 352 ~ \nInternational Journal of Clinical Obstetrics and Gynaecology 2026; 10(5): 352-360 \nISSN (P): 2522-6614 \nISSN (E): 2522-6622 \nIndexing: Embase \nImpact Factor (RJIF): 6.71 \n© Gynaecology Journal \nwww.gynaecologyjournal.com \n2026; 10(5): 352-360 \nReceived: 19-07-2026 \nAccepted: 10-08-2026 \nPublished: 11-09-2026 \nDr. N Aarthi Reddy \nAssociate Professor, Department of \nRadiology, SVS Medical College, \nYenugonda, Mahabubnagar, \nTelangana, India \nDr. Divya Raju Alluri \nAssociate Professor, Department of \nRadiology, SVS Medical College, \nYenugonda, Mahabubnagar, \nTelangana, India \nDr. Harshavardhan Reddy G \nAssistant Professor, Department of \nRadiology, SVS Medical College, \nYenugonda, Mahabubnagar, \nTelangana, India. \nCorresponding Author: \nDr. N Aarthi Reddy \nAssociate Professor, Department of \nRadiology, SVS Medical College, \nYenugonda, Mahabubnagar, \nTelangana, India \nComparison of transvaginal ultrasonography and \nmagnetic resonance imaging in the evaluation of \nadenomyosis: A comparative study \nN Aarthi Reddy, Divya Raju Alluri and Harshavardhan Reddy G \nDOI: https://www.doi.org/10.33545/gynae.2026.v10.i5e.2884 \nAbstract\nBackground: Adenomyosis is a benign uterine disorder that commonly presents with heavy menstrual \nbleeding, dysmenorrhoea, chronic pelvic pain and infertility. Although histopathological examination of \nhysterectomy specimens remains the reference standard, non-invasive imaging has become increasingly \nimportant for preoperative diagnosis. Transvaginal ultrasonography is widely used as a first-line \ninvestigation, whereas magnetic resonance imaging offers superior soft-tissue contrast and detailed \nevaluation of the uterine junctional zone.  \nAim: To compare the diagnostic performance of transvaginal ultrasonography and magnetic resonance \nimaging in the evaluation of adenomyosis.  \nMaterials and Methods: This hos\npital-based comparative cross-sectional diagnostic-accuracy study \nincluded 120 women with clinical suspicion of adenomyosis who underwent hysterectomy at a tertiary-care \nhospital. All participants were evaluated preoperatively using TVUS and pelvic MRI. Imaging findings \nwere compared with histopathological examination of hysterectomy specimens as the reference standard. \nSensitivity, specificity, positive predictive value, negative predictive value, likelihood ratios, diagnostic \naccuracy and diagnostic odds ratios were calculated with 95% confidence intervals. Agreement was \nassessed using Cohen’s kappa coefficient, and the paired diagnostic performance of TVUS and MRI was \ncompared using the exact McNemar test. A p value <0.05 was considered statistically significant.  \nResults: Histopathological examination confirmed adenomyosis in 68 (56.7%) of the 120 participants. \nTVUS correctly identified 57 true-positive and 44 true-negative cases, whereas MRI identified 64 true-\npositive and 49 true-negative cases. TVUS demonstrated sensitivity of 83.8%, specificity of 84.6%, \npositive predictive value of 87.7%, negative predictive value of 80.0% and diagnostic accuracy of 84.2%. \nThe corresponding values for MRI were 94.1%, 94.2%, 95.5%, 92.5% and 94.2%, respectively. MRI had a \nhigher positive likelihood ratio (16.31 versus 5.45), a lower negative likelihood ratio (0.06 versus 0.19) and \na higher diagnostic odds ratio (261.33 versus 28.50). MRI showed almost-perfect agreement with \nhistopathology (κ=0.88; p<0.001), whereas TVUS  showed substantial agreement (κ=0.68; p<0.001). MRI \ndemonstrated significantly higher sensitivity (p=0.039), lower false-negative rate (5.9% versus 16.2%; \np=0.039) and greater overall diagnostic accuracy than TVUS (94.2% versus 84.2%; p=0.004).  \nConclusion: TVUS provided good diagnostic performance and remained a suitable first-line imaging \nmodality for adenomyosis. MRI demonstrated higher sensitivity, accuracy and agreement with \nhistopathology and produced fewer false-negative findings. MRI should be considered when TVUS \nfindings are inconclusive or when detailed assessment of the extent of adenomyosis is required. \nKeywords: Adenomyosis; Transvaginal ultrasonography; Magnetic resonance imaging. \nIntroduction  \nAdenomyosis is a benign uterine disorder characterised by the presence of endometrial glands \nand stroma within the myometrium, accompanied by hypertrophy and hyperplasia of the \nsurrounding smooth muscle. It commonly affects women of reproductive and perimenopausal \nage and may present with heavy menstrual bleeding, progressive dysmenorrhoea, chronic pelvic \npain, dyspareunia, infertility or an enlarged tender uterus. However, some patients remain \nasymptomatic. The clinical presentation frequently overlaps with uterine leiomyomas and \nendometriosis, making diagnosis based only on symptoms and pelvic examination difficult. \nHistorically, adenomyosis was confirmed by histopathological examination of hysterectomy \nspecimens. Increasing use of non-invasive imaging has facilitated preoperative diagnosis and the \nconservative management of women wishing to preserve fertility or avoid hysterectomy [1,2]. \nTransvaginal ultrasonography (TVUS) is generally used as the first-line imaging modality \nbecause it is widely available, relatively inexpensive, well tolerated and capable of providing  \n\n\n~ 353 ~ \n \nreal-time assessment of the uterus. Sonographic features \nsuggestive of adenomyosis include globular uterine enlargement, \nasymmetrical myometrial thickening, myometrial cysts, \nhyperechoic islands, fan -shaped shadowing, echogenic \nsubendometrial lines and buds, translesional vascularity and an \nirregular or interrupted junctional zone. The Morphological \nUterus Sonographic Assessment consensus has improved the \nterminology and standardisation of these findings  [3,4]. \nNevertheless, the diagno stic performance of TVUS remains \ndependent on operator experience, equipment quality and the \npresence of coexisting pelvic abnormalities. \nMagnetic resonance imaging (MRI) provides superior soft-tissue \ncontrast, multiplanar assessment and improved visualisa tion of \nthe uterine junctional zone. MRI findings associated with \nadenomyosis include junctional -zone thickening, an increased \njunctional-zone-to-myometrial thickness ratio, ill -defined areas \nof low signal intensity and small high -signal-intensity \nmyometrial foci on T2 - or T1 -weighted images. MRI may be \nparticularly useful when TVUS findings are inconclusive or \nwhen adenomyosis coexists with leiomyomas or endometriosis. \nHowever, MRI is more expensive, less accessible and \ncontraindicated in certain patients.  Available evidence suggests \nthat both TVUS and MRI have good diagnostic performance, \nalthough results vary according to diagnostic criteria, examiner \nexpertise and the reference standard employed  [2,5]. A direct \ncomparison of these modalities against hist opathological \nfindings may help define their relative diagnostic value and \nguide appropriate imaging choices. Therefore, the present study \ncompared TVUS and MRI in the evaluation of adenomyosis \namong women undergoing hysterectomy. \n \n \nAim \nTo compare the diag nostic performance of transvaginal \nultrasonography and magnetic resonance imaging in the \nevaluation of adenomyosis. \n \nObjectives \n1. To determine the sensitivity, specificity, positive predictive \nvalue, negative predictive value and diagnostic accuracy of \ntransvaginal ultrasonography in detecting adenomyosis.  \n2. To determine the sensitivity, specificity, positive predictive \nvalue, negative predictive value and diagnostic accuracy of \nmagnetic resonance imaging in detecting adenomyosis.  \n3. To compare the findings of t ransvaginal ultrasonography \nand magnetic resonance imaging with histopathological \nexamination and assess their diagnostic agreement.  \n \nMaterial and Methodology \nSource of Data \nThe study participants were recruited from women attending the \noutpatient and inpatient services of the Department of Obstetrics \nand Gynaecology at a tertiary -care teaching hospital. Women \nwho had symptoms or clinical findings suggestive of \nadenomyosis and who were scheduled to undergo hysterectomy \nwere assessed for eligibility. Clinic al information, TVUS \nfindings, MRI findings, operative observations and \nhistopathological results were obtained from clinical \nexamination records, radiological reports, operative notes and \nhistopathology reports. \nStudy Design \nA hospital -based comparative c ross-sectional diagnostic -\naccuracy study was conducted. Both TVUS and MRI were \nperformed in the same participants, and the results of each \nimaging modality were compared with histopathological \nexamination of hysterectomy specimens, which was considered \nthe reference standard. \n \nStudy Location \nThe study was conducted jointly in the Departments of \nObstetrics and Gynaecology, Radiodiagnosis and Pathology. \nStudy Duration \nThe study was conducted over 12 months. This period included \nparticipant recruitment, imagin g assessment, surgical \nmanagement, histopathological examination, data collection and \nstatistical analysis. \n \nSample Size \nA total of 120 eligible women were included in the study. The \nsample size was estimated using the anticipated sensitivity of \nimaging fo r diagnosing adenomyosis, an expected prevalence \namong symptomatic women undergoing hysterectomy, a 95% \nconfidence level and an acceptable absolute precision. It was \ncalculated using the diagnostic-study formula: \n \n \n \nwhere \n at a 95% confidence level, \n represented \nthe anticipated sensitivity, \n represented absolute precision and \nrepresented the anticipated prevalence of adenomyosis. After \nallowing for incomplete investigations or records, the final \nsample size was fixed at 120 participants. Consecutive eligible \nparticipants were recruited until the required sample size was \nachieved. \nInclusion Criteria \nWomen were included when they: \n Were aged 18 years or older.  \n Presented with symptoms or clinical findings sugges tive of \nadenomyosis, such as heavy menstrual bleeding, \ndysmenorrhoea, chronic pelvic pain, dyspareunia or a bulky \ntender uterus.  \n Were scheduled to undergo hysterectomy as part of their \nclinical management.  \n Underwent both TVUS and pelvic MRI before surgery.  \n Provided written informed consent to participate in the \nstudy.  \n Had histopathological examination of the hysterectomy \nspecimen available for comparison.  \n \nExclusion Criteria \nWomen were excluded when they: \n Were pregnant or suspected to be pregnant.  \n Had contraindications to MRI, including non -compatible \nmetallic implants, cardiac pacemakers or severe \nclaustrophobia.  \n Were unwilling or unable to undergo TVUS.  \n Had previously undergone endometrial ablation, uterine \nartery embolisation or conservative surge ry for \nadenomyosis.  \n Had received hormonal treatment that could substantially \n\nInternational Journal of Clinical Obstetrics and Gynaecology https://www.gynaecologyjournal.com \n~ 354 ~ \nalter imaging findings during the preceding three months.  \n Had a known or suspected uterine, cervical or ovarian \nmalignancy.  \n Had technically inadequate TVUS or MRI examinations.  \n Did not undergo hysterectomy or had an \nunavailable/inadequate specimen for histopathological \nexamination.  \n Declined participation or had incomplete essential study \ndata.  \n  \nProcedure and Methodology \nApproval was obtained from the Institutional Ethics Comm ittee \nbefore commencing the study. Written informed consent was \nobtained from every participant. Confidentiality of patient \ninformation was maintained throughout the study. \nA detailed history was recorded, including age, parity, menstrual \npattern, heavy me nstrual bleeding, severity and duration of \ndysmenorrhoea, chronic pelvic pain, dyspareunia, infertility, \nprevious caesarean delivery, uterine surgery and hormonal \ntreatment. General, abdominal and pelvic examinations were \nperformed. Relevant laboratory findings, including haemoglobin \nconcentration, were documented. \n \nTransvaginal ultrasonography \nTVUS was performed using a high -frequency endovaginal \ntransducer, preferably during the early proliferative phase when \nclinically feasible. The urinary bladder was e mptied before \nexamination. The uterus was assessed in sagittal and transverse \nplanes for its position, dimensions, volume, shape, symmetry of \nthe uterine walls, myometrial echotexture and associated pelvic \nabnormalities. \nAdenomyosis was suspected when one or more recognised \nMUSA features were identified, including: \n Myometrial cysts;  \n Hyperechoic islands;  \n Echogenic subendometrial lines or buds;  \n Fan-shaped acoustic shadowing;  \n Globular uterine configuration;  \n Asymmetrical myometrial thickening;  \n Translesional vascularity;  \n An irregular or interrupted junctional zone.  \n \nDirect and indirect features were recorded separately. The \nlocation and extent of suspected adenomyosis, involvement of \nthe inner or outer myometrium and the presence of focal or \ndiffuse disea se were documented. Associated leiomyomas, \nendometriosis or adnexal pathology were also recorded. The \nTVUS examiner recorded the final impression as adenomyosis \npresent or absent. \n \nMagnetic resonance imaging \nPelvic MRI was performed using a 1.5 -Tesla or 3 -Tesla MRI \nsystem with a phased -array pelvic coil. The standard protocol \nincluded multiplanar T2 -weighted sequences and axial T1 -\nweighted sequences, with fat -suppressed sequences wherever \nrequired. Contrast-enhanced imaging was performed only when \nclinically indicated. \nMRI evaluation included uterine size and configuration, \nmyometrial signal intensity, maximum junctional -zone \nthickness, junctional -zone irregularity, the ratio of maximum \njunctional-zone thickness to total myometrial thickness and the \npresence of small high -signal-intensity myometrial foci. \nAdenomyosis was diagnosed when characteristic features such \nas junctional-zone thickening, an ill-defined low-signal-intensity \nmyometrial area or punctate high -signal-intensity foci were \nidentified. The dise ase was classified as focal or diffuse and its \nlocation and extent were recorded. \nWhenever feasible, the radiologist interpreting the MRI was \nblinded to the detailed TVUS interpretation, and the imaging \nspecialists were blinded to the final histopathologic al findings. \nThe interval between imaging and surgery was kept as short as \npractically possible, preferably within four weeks. \nFollowing imaging, the participants underwent hysterectomy \naccording to their clinical indications and institutional treatment \nprotocols. The decision to perform surgery was made by the \ntreating clinician and was independent of participation in the \nstudy. \n \nSample Processing \nImmediately after hysterectomy, the uterus was labelled with a \nunique identification number and transported to  the Department \nof Pathology in 10% neutral -buffered formalin. Gross \nexamination included uterine dimensions, external appearance, \nendometrial cavity, myometrial thickness, areas of haemorrhage, \ncystic changes, trabeculation and coexisting leiomyomas or \nother lesions. \nRepresentative tissue sections were obtained from the anterior \nand posterior uterine walls, fundus, cornual regions and any \ngrossly suspicious myometrial area. The tissue was processed \nroutinely, embedded in paraffin, sectioned at approximatel y 3-5 \nµm and stained with haematoxylin and eosin. \nAdenomyosis was diagnosed histopathologically by the presence \nof endometrial glands and stroma within the myometrium, \naccompanied by surrounding smooth -muscle hypertrophy or \nhyperplasia. The pathologist was  blinded, as far as feasible, to \nthe final imaging diagnosis. Histopathological findings were \ncategorised as adenomyosis present or absent and were used as \nthe reference standard. \n \nStatistical Methods \nData were entered into Microsoft Excel and analysed usi ng IBM \nSPSS Statistics or an equivalent statistical package. Continuous \nvariables were assessed for normality using the Shapiro -Wilk \ntest and graphical methods. Normally distributed variables were \nsummarised as mean and standard deviation with 95% \nconfidence intervals, whereas skewed variables were reported as \nmedian and interquartile range. Categorical variables were \npresented as frequencies and percentages. \nThe diagnostic performances of TVUS and MRI were calculated \nagainst histopathology in terms of: \n Sensitivity;  \n Specificity;  \n Positive predictive value;  \n Negative predictive value;  \n False-positive and false-negative rates;  \n Overall diagnostic accuracy;  \n Positive and negative likelihood ratios.  \n \nAll diagnostic estimates were reported with 95% confidence \nintervals. The chi -square test or Fisher’s exact test was used to \nassess associations between categorical variables. Because \nTVUS and MRI results were obtained from the same \nparticipants, their paired proportions, including sensitivity, \nspecificity and over all accuracy, were compared using \nMcNemar’s test. Agreement between each imaging modality and \nhistopathology was assessed using Cohen’s kappa coefficient. \n\nInternational Journal of Clinical Obstetrics and Gynaecology https://www.gynaecologyjournal.com \n~ 355 ~ \nReceiver operating characteristic curves were constructed for \nrelevant continuous imaging measurement s, such as junctional -\nzone thickness. The area under the curve and its 95% confidence \ninterval were calculated, and an appropriate diagnostic cut -off \nwas identified using the Youden index. A two -sided p value \n<0.05 was considered statistically significant. \n \nData Collection \nData were collected using a predesigned, pretested and \nstructured case -record form. The form contained the following \nsections: \n Sociodemographic details;  \n Obstetric and menstrual history;  \n Presenting symptoms and their duration;  \n Previous medical, hormonal and surgical history;  \n General and pelvic examination findings;  \n TVUS characteristics and diagnostic impression;  \n MRI characteristics and diagnostic impression;  \n Operative details;  \n Gross pathological findings;  \n Final histopathological diagnosis.  \n \nEach participant was assigned a unique study code. The \ncompleted forms were checked regularly for accuracy, \nconsistency and completeness. Data were entered into a \npassword-protected electronic database, and participant \nidentifiers were removed before statistical analysis. \n \nObservation and Results \n \nTable 1: Comparison of the diagnostic performance of TVUS and MRI for adenomyosis (N=120) \n \nDiagnostic parameter TVUS, n/N (%) 95% CI MRI, n/N (%) 95% CI Test of significance p value \nSensitivity 57/68 (83.8) 73.3-90.7 64/68 (94.1) 85.8-97.7 Exact McNemar test 0.039 \nSpecificity 44/52 (84.6) 72.5-92.0 49/52 (94.2) 84.4-98.0 Exact McNemar test 0.125 \nPositive predictive value 57/65 (87.7) 77.5-93.6 64/67 (95.5) 87.6-98.5 Difference=7.8% 0.103 \nNegative predictive value 44/55 (80.0) 67.6-88.4 49/53 (92.5) 82.1-97.0 Difference=12.5% 0.061 \nDiagnostic accuracy 101/120 (84.2) 76.6-89.6 113/120 (94.2) 88.4-97.1 Exact McNemar test 0.004 \nFalse-positive rate 8/52 (15.4) 8.0-27.5 3/52 (5.8) 2.0-15.6 Exact McNemar test 0.125 \nFalse-negative rate 11/68 (16.2) 9.3-26.7 4/68 (5.9) 2.3-14.2 Exact McNemar test 0.039 \nPositive likelihood ratio 5.45 2.88-10.31 16.31 5.44-48.88     \nNegative likelihood ratio 0.19 0.11-0.34 0.06 0.02-0.15     \nDiagnostic odds ratio 28.50 10.57-76.86 261.33 55.88-1222.08     \n \nTable 1 compares the diagnostic performance of TVUS and MRI \nfor detecting adenomyosis among 120 participants. MRI \ndemonstrated significantly greater sensitivity than TVUS (94.1% \nversus 83.8%; p=0.039). Although MRI also  showed higher \nspecificity (94.2% versus 84.6%), the difference was not \nstatistically significant (p=0.125). The positive predictive value \nwas 95.5% for MRI and 87.7% for TVUS (p=0.103), while the \ncorresponding negative predictive values were 92.5% and 80.0% \n(p=0.061). MRI achieved significantly higher overall diagnostic \naccuracy than TVUS (94.2% versus 84.2%; p=0.004). MRI also \nhad lower false -positive (5.8% versus 15.4%; p=0.125) and \nsignificantly lower false -negative rates (5.9% versus 16.2%; \np=0.039). F urthermore, MRI had a higher positive likelihood \nratio (16.31 versus 5.45), a lower negative likelihood ratio (0.06 \nversus 0.19) and a substantially higher diagnostic odds ratio \n(261.33 versus 28.50), indicating superior diagnostic \nperformance. \n \nA. TVUS-histopathology cross-classification \n \nTable 2: Diagnostic performance of TVUS for detecting adenomyosis using histopathology as the reference standard (N=120) \n \nTVUS finding Histopathology positive, n (%) Histopathology negative, n (%) Total, n (%) \nPositive for adenomyosis 57 (47.5) True positive 8 (6.7) False positive 65 (54.2) \nNegative for adenomyosis 11 (9.2) False negative 44 (36.7) True negative 55 (45.8) \nTotal 68 (56.7) 52 (43.3) 120 (100.0) \nAssociation between TVUS and histopathological diagnosis: χ²=55.59, p<0.001. \n \nB. Diagnostic indices of TVUS \n \nDiagnostic index Estimate 95% CI Test statistic p value \nSensitivity 83.8% 73.3-90.7     \nSpecificity 84.6% 72.5-92.0     \nPositive predictive value 87.7% 77.5-93.6     \nNegative predictive value 80.0% 67.6-88.4     \nDiagnostic accuracy 84.2% 76.6-89.6     \nPositive likelihood ratio 5.45 2.88-10.31     \nNegative likelihood ratio 0.19 0.11-0.34     \nDiagnostic odds ratio 28.50 10.57-76.86 χ²=55.59 <0.001 \nAgreement with histopathology κ=0.68 0.55-0.81 Z=7.47 <0.001 \n \nTable 2 presents the diagnostic performance of TVUS using \nhistopathology as the reference standard. Histopathological \nexamination confirmed adenomyosis in 68 (56.7%) participants \nand excluded it in 52 (43.3%). TVUS correctly identified 57 \n\nInternational Journal of Clinical Obstetrics and Gynaecology https://www.gynaecologyjournal.com \n~ 356 ~ \ntrue-positive cases and 44 true-negative cases, while producing 8 \nfalse-positive and 11 false -negative results. TVUS had a \nsensitivity of 83.8% (95% CI: 73.3 -90.7), specificity of 84.6% \n(95% CI: 72.5 -92.0), positive predictive value of 87.7% (95% \nCI: 77.5 -93.6), negative predictive value of 80.0% (95% CI: \n67.6-88.4) and overall diagnostic accuracy of 84.2% (95% CI: \n76.6-89.6). Its positive and negative likelihood ratios were 5.45 \nand 0.19, respectively. The diagnostic odds ratio was 28.50 \n(95% CI: 10.57 -76.86), and the association between TVUS and \nhistopathological diagnosis was statistically significant \n(χ²=55.59, p<0.001). TVUS also demonstrated substantial \nagreement with histopathology (κ=0.68; 95% CI: 0.55 -0.81; \nZ=7.47; p<0.001). \n \nA. MRI-histopathology cross-classification \n \nTable 3: Diagnostic performance of MRI for detecting adenomyosis using histopathology as the reference standard (N=120) \n \nMRI finding Histopathology positive, n (%) Histopathology negative, n (%) Total, n (%) \nPositive for adenomyosis 64 (53.3) True positive 3 (2.5) False positive 67 (55.8) \nNegative for adenomyosis 4 (3.3) False negative 49 (40.8) True negative 53 (44.2) \nTotal 68 (56.7) 52 (43.3) 120 (100.0) \nAssociation between MRI and histopathological diagnosis: χ²=93.27, p<0.001. \n \nB. Diagnostic indices of MRI \n \nDiagnostic index Estimate 95% CI Test statistic p value \nSensitivity 94.1% 85.8-97.7     \nSpecificity 94.2% 84.4-98.0     \nPositive predictive value 95.5% 87.6-98.5     \nNegative predictive value 92.5% 82.1-97.0     \nDiagnostic accuracy 94.2% 88.4-97.1     \nPositive likelihood ratio 16.31 5.44-48.88     \nNegative likelihood ratio 0.06 0.02-0.15     \nDiagnostic odds ratio 261.33 55.88-1222.08 χ²=93.27 <0.001 \nAgreement with histopathology κ=0.88 0.78-0.98 Z=9.66 <0.001 \n \nTable 3 shows the diagnostic performance of MRI using \nhistopathological examination as the reference standard. MRI \ncorrectly identified 64 of the 68 histopathologically positive \ncases and 49 of the 52 histopathologically negative cases. Only 3 \nfalse-positive and 4 false -negative results were observed. MRI \ndemonstrated a sensitivity of 94.1% (95% CI: 85.8 -97.7), \nspecificity of 94.2% (95% CI: 84.4 -98.0), positive predictive \nvalue of 95.5% (95% CI: 87.6 -98.5), negative predictive value \nof 92.5% (95% CI: 82.1-97.0) and diagnostic accuracy of 94.2% \n(95% CI: 88.4 -97.1). The positive likelihood ratio was 16.31, \nwhereas the negative likelihood ratio was 0.06. The diagnostic \nodds ratio was 261.33 (95% CI: 55.88 -1222.08), and MRI \nfindings were significantly associated with histopathological \ndiagnosis (χ²=93.27, p<0.001). MRI demonstrated almost -\nperfect agreement with histopathology (κ=0.88; 95% CI: 0.78 -\n0.98; Z=9.66; p<0.001). \n \nA. Agreement of each imaging modality with histopathology \n \nTable 4: Agreement and paired comparison of TVUS and MRI findings with histopathology (N=120) \n \nComparison Observed agreement, n/N (%) 95% CI Cohen’s κ 95% CI for κ Strength of agreement Test statistic p value \nTVUS versus histopathology 101/120 (84.2) 76.6-89.6 0.68 0.55-0.81 Good/substantial Z=7.47 <0.001 \nMRI versus histopathology 113/120 (94.2) 88.4-97.1 0.88 0.78-0.98 Almost perfect Z=9.66 <0.001 \nTVUS versus MRI diagnosis 104/120 (86.7) 79.4-91.6 0.73 0.61-0.85 Good/substantial Z=8.03 <0.001 \n \nB. Paired comparison of correctly classified cases \n \nTVUS classification MRI correct, n (%) MRI incorrect, n (%) Total, n (%) \nTVUS correct 99 (82.5) 2 (1.7) 101 (84.2) \nTVUS incorrect 14 (11.7) 5 (4.2) 19 (15.8) \nTotal 113 (94.2) 7 (5.8) 120 (100.0) \nExact McNemar test comparing overall diagnostic accuracy: p=0.004. \n \nC. Summary of paired diagnostic differences \n \nDiagnostic comparison TVUS MRI Absolute difference Test p value \nCorrectly classified cases 101 (84.2%) 113 (94.2%) +10.0 percentage points Exact McNemar 0.004 \nHistopathology-positive cases detected 57/68 (83.8%) 64/68 (94.1%) +10.3 percentage points Exact McNemar 0.039 \nHistopathology-negative cases correctly excluded 44/52 (84.6%) 49/52 (94.2%) +9.6 percentage points Exact McNemar 0.125 \nFalse-negative cases 11/68 (16.2%) 4/68 (5.9%) −10.3 percentage points Exact McNemar 0.039 \nFalse-positive cases 8/52 (15.4%) 3/52 (5.8%) −9.6 percentage points Exact McNemar 0.125 \n \n\nInternational Journal of Clinical Obstetrics and Gynaecology https://www.gynaecologyjournal.com \n~ 357 ~ \nTable 4 demonstrates the agreement and paired comparison of \nTVUS and MRI with histopathological findings. TVUS agreed \nwith histopathology in 101 of 120 cases, producing an observed \nagreement of 84.2% (95% CI: 76.6 -89.6) and substantial \nagreement beyond chance (κ=0.68; p<0.001). MRI agreed with \nhistopathology in 113 cas es, corresponding to an observed \nagreement of 94.2% (95% CI: 88.4 -97.1) and almost -perfect \nagreement (κ=0.88; p<0.001). Agreement between TVUS and \nMRI diagnoses was 86.7% (κ=0.73; 95% CI: 0.61 -0.85; \np<0.001). Both modalities correctly classified 99 (82.5%)  cases; \nhowever, MRI correctly classified 14 cases that were incorrectly \nclassified by TVUS, whereas TVUS correctly classified only 2 \ncases that were incorrectly classified by MRI. Consequently, \nMRI showed significantly higher overall accuracy than TVUS \n(94.2% versus 84.2%; exact McNemar p=0.004). MRI detected \n10.3 percentage points more histopathology -positive cases \n(p=0.039) and reduced the false-negative rate by 10.3 percentage \npoints (p=0.039). Although MRI also correctly excluded 9.6 \npercentage points more disease-negative cases and reduced the \nfalse-positive rate by 9.6 percentage points, these differences \nwere not statistically significant (p=0.125). \n \nDiscussion \nIn the present comparative study of 120 women, \nhistopathological examination confirmed ade nomyosis in 68 \n(56.7%) participants. Both transvaginal ultrasonography (TVUS) \nand magnetic resonance imaging (MRI) demonstrated good \ndiagnostic performance; however, MRI consistently produced \nhigher sensitivity, specificity, predictive values, diagnostic \naccuracy and agreement with histopathology. The improved \nperformance of MRI was particularly evident in its lower false -\nnegative rate and significantly higher overall diagnostic \naccuracy. These findings support the use of TVUS as the initial \nimaging investi gation and MRI as a valuable second -line or \nproblem-solving modality, especially when TVUS findings are \ninconclusive or complex coexisting uterine pathology is present. \n \nComparison of TVUS and MRI diagnostic performance \nThe sensitivity of MRI in the presen t study was significantly \nhigher than that of TVUS (94.1% versus 83.8%; p=0.039). MRI \nalso showed higher specificity (94.2% versus 84.6%), although \nthis difference was not statistically significant (p=0.125). \nSimilarly, MRI demonstrated higher positive and  negative \npredictive values than TVUS. The overall diagnostic accuracy \nwas 94.2% for MRI compared with 84.2% for TVUS, \nrepresenting a significant absolute improvement of 10 \npercentage points (p=0.004). \nVan den Bosch et al . (2015) [1] developed the Morpholo gical \nUterus Sonographic Assessment terminology to standardise the \nreporting of myometrial and junctional -zone abnormalities. \nTheir consensus identified myometrial cysts, hyperechoic \nislands, fan -shaped shadowing, asymmetrical myometrial \nthickening, transl esional vascularity and junctional -zone \nirregularity as important sonographic features of adenomyosis. \nConsistent application of these criteria may explain the relatively \nhigh TVUS sensitivity observed in the present study. \nPinzauti et al . (2015) [2] reported that TVUS performed by \nexperienced examiners could reliably identify adenomyosis \nbefore surgery. However, they also emphasised that diagnostic \nperformance depended on examiner expertise and the presence \nof coexisting uterine lesions. Bazot and Daraï (2018) [3] similarly \nobserved that TVUS and MRI were the principal non -invasive \ndiagnostic modalities, with MRI providing superior tissue \ncharacterisation and more objective evaluation of the junctional \nzone. \nIn a systematic review and meta-analysis, Andres et al. (2018) [4] \nconcluded that TVUS had good diagnostic performance and \ncould be used as a first -line investigation for adenomyosis. \nHowever, variation in individual sonographic criteria and \noperator experience contributed to heterogeneity across studies . \nLiu et al . (2019) [5] compared commonly used diagnostic \napproaches and found that both TVUS and MRI had clinically \nuseful accuracy, although MRI generally showed greater \nspecificity. This is consistent with the present finding of 94.2% \nspecificity for MRI compared with 84.6% for TVUS. \nTellum et al . (2020) [6] found comparable overall diagnostic \nability for TVUS and MRI in their meta -analysis, but MRI \nshowed an advantage in specificity and in diagnostically difficult \ncases. Chapron et al . (2020) [7] recommended an integrated \nclinical and imaging approach and observed that expert TVUS \ncould perform well, while MRI was helpful for lesion mapping, \ndisease classification and assessment of the junctional zone. The \npresent findings similarly demonstrated that bot h modalities \nwere diagnostically useful, although MRI achieved significantly \nhigher accuracy. \nThe higher MRI performance in this study could be attributed to \nits superior soft-tissue contrast, multiplanar capability and ability \nto demonstrate junctional -zone thickening, myometrial signal \nabnormalities and small haemorrhagic or cystic foci. By \ncontrast, TVUS performance may be influenced by uterine \nposition, obesity, coexisting leiomyomas and operator \ninterpretation. Harmsen et al . (2022) [8] revised the MUS A \ndefinitions by dividing sonographic signs into direct and indirect \nfeatures, thereby improving their clinical interpretation and \nreproducibility. Application of these revised criteria may further \nimprove future TVUS performance. \n \nDiagnostic performance of TVUS \nTVUS correctly detected 57 of the 68 histopathologically \nconfirmed cases and correctly excluded disease in 44 of the 52 \nhistopathology-negative participants. It produced 8 false-positive \nand 11 false -negative findings. Its sensitivity was 83.8%, \nspecificity 84.6%, positive predictive value 87.7%, negative \npredictive value 80.0% and diagnostic accuracy 84.2%. The \ndiagnostic odds ratio was 28.50, and TVUS demonstrated \nsubstantial agreement with histopathology (κ=0.68, p<0.001). \nThe TVUS sensitivity obs erved in this study was higher than \nsome pooled estimates reported by Andres et al. (2018) [4] and \nTellum et al . (2020) [6]. This may reflect differences in study \npopulations, prevalence, sonographer expertise, equipment \nquality and the number of sonograph ic criteria required for \ndiagnosis. Studies limited to women undergoing hysterectomy \nmay also contain a higher proportion of advanced or diffuse \nadenomyosis, in which ultrasonographic features are more \napparent. \nVannuccini et al . (2017) [9] explained that adenomyosis may \noccur in diffuse, focal or mixed forms and is frequently \nassociated with smooth -muscle hypertrophy and disruption of \nthe endometrial -myometrial junction. These variable \npathological patterns may explain false-negative TVUS findings, \nparticularly in early or focal disease. Abbott (2017) [10] also \nnoted that adenomyosis is a heterogeneous disorder and that \nvariations in diagnostic criteria contribute to inconsistencies \nbetween imaging and histopathology. \nExacoustos et al. (2020) [11] demonstrated that the number and \ntype of ultrasound features were associated with the severity and \ndistribution of adenomyosis. Direct signs, such as myometrial \ncysts and hyperechoic islands, were generally more specific, \n\nInternational Journal of Clinical Obstetrics and Gynaecology https://www.gynaecologyjournal.com \n~ 358 ~ \nwhereas indirect signs, such as a globular uterus and \nasymmetrical wall thickening, could also occur with leiomyomas \nor other myometrial disorders. This could explain the eight false-\npositive TVUS findings in the present study. \nTellum et al. (2020) [12] reported that individual ultrasound signs \ndid not have uniform diagnostic value and that combining \nseveral features improved diagnostic confidence. Rasmussen et \nal. (2019) [13] similarly found that interobserver agreement \ndiffered across ultrasonographic features, indicating that \nexaminer training and standardised reporting are essential. In the \npresent study, the positive likelihood ratio of 5.45 indicated that \na positive TVUS result produced a moderate increase in the \nprobability of adenomyosis, while the negative likelihood ratio \nof 0.19 showed tha t a negative examination substantially \nreduced but did not completely exclude the disease. \nThe substantial agreement between TVUS and histopathology \n(κ=0.68) suggests that TVUS was clinically reliable but not \ninterchangeable with the reference standard. Va n den Bosch et \nal. (2019) [14] highlighted that structured assessment of the \nmyometrium and junctional zone could improve diagnostic \nreproducibility. Therefore, TVUS remains an appropriate first -\nline modality because it is inexpensive, widely available and  \nprovides real -time assessment without radiation exposure. \nNevertheless, negative TVUS findings should be interpreted \ncautiously when clinical suspicion remains high. \n \nDiagnostic performance of MRI \nMRI correctly identified 64 of the 68 histopathologically \npositive cases and correctly excluded adenomyosis in 49 of the \n52 disease -negative participants. Only 3 false -positive and 4 \nfalse-negative findings were recorded. MRI demonstrated \nsensitivity of 94.1%, specificity of 94.2%, positive predictive \nvalue of 95 .5%, negative predictive value of 92.5% and overall \ndiagnostic accuracy of 94.2%. Its positive likelihood ratio was \n16.31, negative likelihood ratio was 0.06 and diagnostic odds \nratio was 261.33. These findings indicated that MRI was highly \neffective for both confirming and excluding adenomyosis. \nAgostinho et al . (2017) [15] described MRI as a highly useful \nmodality for evaluating adenomyosis because of its ability to \nidentify junctional -zone thickening, ill -defined low -signal-\nintensity areas and high -signal-intensity myometrial foci. The \nauthors also cautioned that junctional -zone thickness could be \ninfluenced by age, menstrual phase, hormonal status and \ntransient uterine contractions. These factors could account for \noccasional false-positive or false-negative MRI findings. \nBazot and Daraï (2018) [3] reported that MRI was especially \nvaluable when ultrasonographic findings were equivocal or \nwhen adenomyosis coexisted with uterine leiomyomas. The high \nMRI specificity in the present study supports this observat ion. \nTellum et al. (2020) [6] also found that MRI generally provided \nhigher specificity than TVUS, although pooled sensitivity \nestimates varied across studies. \nMoawad et al . (2022) [16] observed that MRI offered more \nobjective evaluation of the junctional zone and better definition \nof focal versus diffuse adenomyosis. They recommended MRI \nwhen TVUS was inconclusive, when coexisting pathology was \nsuspected or when detailed mapping was needed before fertility -\npreserving treatment. Harmsen et al. (2023) [17] emphasised that \nthe junctional zone is defined differently on TVUS, MRI and \nhistology. This lack of direct anatomical equivalence may \ncontribute to disagreement among modalities, even when \nexaminations are performed correctly. \nDason et al . (2023) [18] recommended TVUS as the initial \ninvestigation for suspected adenomyosis and MRI as a second -\nline modality when additional characterisation was required. The \npresent results support this sequential approach but also indicate \nthat MRI may be preferable when avoiding a missed diagnosis is \nclinically important. The MRI positive likelihood ratio of 16.31 \nprovided strong evidence for confirming adenomyosis, whereas \nits negative likelihood ratio of 0.06 indicated that a negative \nMRI result made the disease highly unlikely. \nMishra et al . (2023) [19] reported that MRI demonstrated high \nconcordance with histopathology, particularly when junctional -\nzone measurements were combined with myometrial signal \nabnormalities. Similarly, the present study recorded almost -\nperfect MRI -histopathology agreement (κ=0.88). Nevertheless, \nMRI should not be considered infallible because mild superficial \nadenomyosis and small isolated foci may remain below spatial \nresolution, while uterine contractions can sometimes simulate \nfocal junctional-zone thickening. \n \nAgreement with histopathology and paired diagnostic \ncomparison \nTVUS agreed with histopathology in 84.2% of cases and \ndemonstrated substantial agreement (κ=0.68). MRI agreed with \nhistopathology in 94.2% and demonstrated almost -perfect \nagreement (κ=0.88). Agreement between TVUS and MRI was \n86.7% (κ=0.73). Thus, the modalities generally classified the \nsame participants similarly, but MRI showed closer concordance \nwith the histopathological diagnosis. \nIn the paired analysis, MRI correctly classi fied 14 cases that \nwere incorrectly classified by TVUS, whereas TVUS correctly \nclassified only 2 cases missed by MRI. MRI detected an \nadditional 10.3% of histopathology -positive cases and \nsignificantly reduced the false-negative rate from 16.2% to 5.9% \n(p=0.039). Its improvement in specificity and false -positive rate \ndid not reach statistical significance, possibly because only 52 \nparticipants were histopathologically negative. \nKho et al. (2021) [20] described adenomyosis as a heterogeneous \ncondition for which histopathological confirmation itself may be \ninfluenced by the number and location of tissue sections \nexamined. Consequently, imaging -histopathology disagreement \nmay partly reflect differences in sampling rather than imaging \nfailure alone. Kobayashi et al. (2021) [21] further demonstrated \nthat early and advanced pathological subtypes possess different \nmorphological appearances, potentially affecting detection by \nboth TVUS and MRI. \nMunro (2019) [22] noted that imaging -based diagnosis has \nbecome increasingly important because hysterectomy specimens \nare unavailable in women undergoing conservative management. \nThe substantial agreement observed for TVUS supports its role \nin routine screening and initial evaluation. Nevertheless, the \nalmost-perfect MRI agreem ent and significantly lower false -\nnegative rate suggest that MRI offers added value in women \nwith persistent symptoms, inconclusive TVUS, coexisting \nleiomyomas, suspected focal disease or planned conservative \nsurgery. \n \nConclusion \nBoth transvaginal ultrason ography and magnetic resonance \nimaging were effective non -invasive modalities for evaluating \nadenomyosis. TVUS demonstrated good sensitivity, specificity \nand substantial agreement with histopathology, supporting its \nuse as an accessible and cost -effective first-line investigation. \nHowever, MRI showed significantly higher sensitivity and \noverall diagnostic accuracy, stronger agreement with \nhistopathology and a lower false -negative rate. MRI may \ntherefore be particularly valuable when TVUS findings are \n\nInternational Journal of Clinical Obstetrics and Gynaecology https://www.gynaecologyjournal.com \n~ 359 ~ \ninconclusive, coexisting uterine abnormalities are present or \naccurate disease mapping is required. A sequential approach \ninvolving initial TVUS followed by MRI in selected patients \nmay provide reliable and efficient diagnosis of adenomyosis. \n \nLimitations \n1. The study was conducted at a single tertiary -care hospital, \nwhich may limit the generalisability of the findings to other \nhealthcare settings.  \n2. The sample size of 120 participants was relatively modest, \nparticularly for subgroup analyses based on focal or diffus e \nadenomyosis.  \n3. Only women who underwent hysterectomy and had an \navailable histopathological diagnosis were included. This \nmay have introduced selection or verification bias and \nincreased the proportion of women with severe symptoms \nor advanced disease.  \n4. The diagnostic performance observed in this surgical \npopulation may not be directly applicable to younger \nwomen, asymptomatic women or those receiving \nconservative treatment.  \n5. TVUS is operator -dependent; therefore, its diagnostic \nperformance may have been i nfluenced by the experience \nand expertise of the examining sonographer.  \n6. MRI interpretation may have been affected by variations in \nmenstrual-cycle phase, junctional -zone appearance, \ntransient uterine contractions and coexisting leiomyomas.  \n7. Complete blind ing between clinical information and \nimaging findings might not have been possible in every \nparticipant, creating a possibility of observer bias.  \n8. Interobserver and intraobserver variability in TVUS, MRI \nand histopathological interpretation was not evaluated.  \n9. The diagnostic performances of individual MUSA \nsonographic features and separate MRI criteria were not \nanalysed.  \n10. The study did not assess the cost -effectiveness, \naccessibility, examination time or patient acceptability of \nTVUS and MRI.  \n \nConflict of Interest \nNot available  \n \nFinancial Support  \nNot available \n \nReferences \n1. Van den Bosch T, Dueholm M, Leone FPG, Valentin L, \nRasmussen CK, Votino A, et al . Terms, definitions  and \nmeasurements to describe sonographic features of \nmyometrium and uterine masses: a consensus opinion from \nthe Morphological Uterus Sonographic Assessment group. \nUltrasound Obstet Gynecol. 2015;46(3):284-298. \n2. Pinzauti S, Lazzeri L, Tosti C, Centini G, Orlandini C, Luisi \nS, et al . Transvaginal sonographic features of diffuse \nadenomyosis in 18 -30-year-old nulligravid women without \nendometriosis: association with symptoms. Ultrasound \nObstet Gynecol. 2015;46(6):730-736. \n3. Bazot M, Daraï E. Role of transvaginal  sonography and \nmagnetic resonance imaging in the diagnosis of uterine \nadenomyosis. Fertil Steril. 2018;109(3):389-397. \n4. Andres MP, Borrelli GM, Ribeiro J, Baracat EC, Abrão MS, \nKho RM. Transvaginal ultrasound for the diagnosis of \nadenomyosis: systematic review and meta-analysis. J Minim \nInvasive Gynecol. 2018;25(2):257-264. \n5. Liu L, Li W, Leonardi M, Condous G, Da Silva Costa F, \nMol BW, et al . Diagnostic accuracy of transvaginal \nultrasound and magnetic resonance imaging for \nadenomyosis: systematic review and meta-analysis. J \nUltrasound Med. 2019;38(12):3311-3324. \n6. Tellum T, Nygaard S, Lieng M. Noninvasive diagnosis of \nadenomyosis: a structured review and meta -analysis of \ndiagnostic accuracy in imaging. J Minim Invasive Gynecol. \n2020;27(2):408-418.e3. \n7. Chapron C, Vannuccini S, Santulli P, Abrão MS, Carmona \nF, Fraser IS, et al. Diagnosing adenomyosis: an integrated \nclinical and imaging approach. Hum Reprod Update. \n2020;26(3):392-411. \n8. Harmsen MJ, Van den Bosch T, de Leeuw RA, Dueholm \nM, Exacoustos C, Valentin L, et al. Consensus on revised \ndefinitions of Morphological Uterus Sonographic \nAssessment features of adenomyosis: results of a modified \nDelphi procedure. Ultrasound Obstet Gynecol. \n2022;60(1):118-131. \n9. Vannuccini S, Tosti C, Carmona F, Huang SJ, Chapron C, \nGuo SW, et al. Pathogenesis of adenomyosis: an update on \nmolecular mechanisms. Reprod Biomed Online. \n2017;35(5):592-601. \n10. Abbott JA. Adenomyosis and abnormal uterine bleeding: \nreview of the evidence. Best Pract Res Clin Obstet \nGynaecol. 2017;40:68-81. \n11. Exacoustos C, Morosetti G, Conway F, Camilli S, Martire \nFG, Lazzeri L, et al . New sonographic classification of \nadenomyosis: do type and degree of adenomyosis correlate \nto severity of symptoms? J Minim Invasive Gynecol. \n2020;27(6):1308-1315. \n12. Tellum T, Matic GV, Dorm agen JB, Nygaard S, Viktil E, \nQvigstad E, et al . Diagnosing adenomyosis with MRI: a \nprospective study revisiting the junctional -zone-thickness \ncutoff of 12 mm as a diagnostic marker. Eur Radiol. \n2019;29(12):6971-6981. \n13. Rasmussen CK, Hansen ES, Dueholm M. In ter-rater \nagreement in the diagnosis of adenomyosis by two - and \nthree-dimensional transvaginal ultrasonography. Ultrasound \nObstet Gynecol. 2019;54(4):512-518. \n14. Van den Bosch T, de Bruijn AM, de Leeuw RA, Dueholm \nM, Exacoustos C, Valentin L, et al . Sonograph ic \nclassification and reporting system for diagnosing \nadenomyosis. Ultrasound Obstet Gynecol. 2019;53(5):576 -\n582. \n15. Agostinho L, Cruz R, Osório F, Alves J, Setúbal A, Guerra \nA. MRI for adenomyosis: a pictorial review. Insights \nImaging. 2017;8(6):549-556. \n16. Moawad G, Fruscalzo A, Youssef Y, Kheil M, Tawil T, \nNehme J, et al . Adenomyosis: an updated review on \ndiagnosis and classification. J Clin Med. 2022;11(16):4828. \n17. Harmsen MJ, Trommelen LM, de Leeuw RA, Tellum T, \nJuffermans LJM, Van den Bosch T, et al. Uterine junctional \nzone and adenomyosis: comparison of MRI, transvaginal \nultrasound and histology. Ultrasound Obstet Gynecol. \n2023;62(1):42-60. \n18. Dason ES, Maxim M, Sanders AP, Papillon -Smith J, Thiel \nJA. Guideline No. 437: diagnosis and management of \nadenomyosis. J  Obstet Gynaecol Can. 2023;45(6):417 -\n429.e1. \n19. Mishra P, Dash S, Jena SK, Behera S. Comparison of \nmagnetic resonance imaging and transvaginal \nultrasonography in the diagnosis of adenomyosis with \nhistopathological correlation. J Obstet Gynaecol India. \n\nInternational Journal of Clinical Obstetrics and Gynaecology https://www.gynaecologyjournal.com \n~ 360 ~ \n2023;73(4):342-349. \n20. Kho KA, Chen JS, Halvorson LM. Diagnosis, evaluation, \nand treatment of adenomyosis. JAMA. 2021;326(2):177 -\n178. \n21. Kobayashi H, Matsubara S, Imanaka S. Clinicopathological \nfeatures of different subtypes in adenomyosis: focus on \nearly lesions. PLoS One. 2021;16(7). \n22. Munro MG. Classification and reporting systems for \nadenomyosis. J Minim Invasive Gynecol. 2019;26(2):197 -\n199. \n \n \nHow to Cite This Article \nReddy NA, Alluri DR, Reddy GH.  Comparison of transvaginal \nultrasonography and magnetic resonance ima ging in the evaluation of \nadenomyosis: A comparative study . International Journal of Clinical \nObstetrics and Gynaecology. 2026;10(5):352-360.  \n \n \nCreative Commons (CC) License \nThis is an open access journal, and articles are distributed under the terms \nof the C reative Commons Attribution -Non-Commercial-Share Alike 4.0 \nInternational (CC BY -NC-SA 4.0) License, which allows others to remix, \ntweak, and build upon the work non -commercially, as long as appropriate \ncredit is given and the new creations are licensed under the identical terms.","source_license":"CC0","license_restricted":false}